← Open Payments lookup

MARK MELDEN: Open Payments

NPI 1982653135 · CORONADO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,500 in 115 payments from 19 companies in 2025. Trend: 2023 $997 · 2024 $1,259 · 2025 $2,500

Food & beverage: $2,388Education: $111
CompanyPaymentsAmount
ABBVIE INC.19$380
Neurocrine BioSciences, Inc.11$267
Teva Pharmaceuticals USA, Inc.7$254
Otsuka America Pharmaceutical, Inc.12$229
E.R. Squibb & Sons, L.L.C.11$215
Lundbeck LLC7$179
Axsome Therapeutics, Inc.8$160
Vanda Pharmaceuticals Inc.12$144
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$143
Indivior Inc.4$106

Products named: VRAYLAR, REXULTI, INGREZZA, COBENFY, Auvelity, FANAPT, CAPLYTA, SUBLOCADE.

Industry payments across CA — which companies pay providers there.